Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.

The Australian medicines regulator has issued a mental health safety warning for a drug widely used for weight loss.

Interest in the field intensified after neurologist Sue Grigson of Pennsylvania State University heard from a man who said he achieved his first ...

The Australian medicines regulator has issued a mental health safety warning for a drug widely used for weight loss.

A new meta-analysis of 31 preclinical studies suggests GLP-1 drugs like semaglutide may reduce ischemic stroke severity in ...

Easier to take, just as effective and far cheaper than fat jab rivals such as Ozempic and Mounjaro, a promising new pill is ...

No significant increase in hazard ratios seen for GI events for semaglutide versus dulaglutide, tirzepatide versus dulaglutide, tirzepatide versus semaglutide. (HealthDay News) — For patients with ...

Please provide your email address to receive an email when new articles are posted on . Dulaglutide, semaglutide and tirzepatide had similar GI safety profiles. An increased risk for GI adverse events ...

HOUSTON — The dual GLP-1/GIP receptor agonist tirzepatide showed significantly greater efficacy than the GLP-1 dulaglutide in the treatment of major kidney outcomes in patients with type 2 diabetes ...

A prespecified analysis of the SURPASS CVOT trial examining patients with high-risk CKD suggested tirzepatide reduces the risk of major kidney events, particularly eGFR decline and albuminuria, ...

Trials have shown that semaglutide can reduce major cardiovascular events, but the extent of tirzepatide’s heart protection ...

MONDAY, Nov. 24, 2025 (HealthDay News) — Researchers say a woman struggling with obesity who couldn’t resist eating fatty ...